ALPHA TRIBE

Lupin LimitedUpdates, 09-10-2025: Press Release

09-10-2025 | 03:01 pm

Lupin initiated a strategic partnership program for its FDA-approved PrecisionSphere™ Long-Acting Injectable (LAI) platform. This aims to collaborate with firms, extending product lifecycles & market reach through improved drug delivery and enhanced patient compliance, signaling strong growth potential.

No comments yet. Be the first to comment!

All announcements from Lupin Limited